Last reviewed · How we verify
PEGylated recombinant candida urate oxidase
PEGylated recombinant candida urate oxidase is a Small molecule drug developed by Shenyang Sunshine Pharmaceutical Co., LTD.. It is currently in Phase 1 development. Also known as: SSS11.
At a glance
| Generic name | PEGylated recombinant candida urate oxidase |
|---|---|
| Also known as | SSS11 |
| Sponsor | Shenyang Sunshine Pharmaceutical Co., LTD. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia (PHASE1)
- A Study to Determine the Safety, Tolerability, PK and Preliminary PD of SSS11 in Chinese Healthy Adult Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PEGylated recombinant candida urate oxidase CI brief — competitive landscape report
- PEGylated recombinant candida urate oxidase updates RSS · CI watch RSS
- Shenyang Sunshine Pharmaceutical Co., LTD. portfolio CI
Frequently asked questions about PEGylated recombinant candida urate oxidase
What is PEGylated recombinant candida urate oxidase?
PEGylated recombinant candida urate oxidase is a Small molecule drug developed by Shenyang Sunshine Pharmaceutical Co., LTD..
Who makes PEGylated recombinant candida urate oxidase?
PEGylated recombinant candida urate oxidase is developed by Shenyang Sunshine Pharmaceutical Co., LTD. (see full Shenyang Sunshine Pharmaceutical Co., LTD. pipeline at /company/shenyang-sunshine-pharmaceutical-co-ltd).
Is PEGylated recombinant candida urate oxidase also known as anything else?
PEGylated recombinant candida urate oxidase is also known as SSS11.
What development phase is PEGylated recombinant candida urate oxidase in?
PEGylated recombinant candida urate oxidase is in Phase 1.
Related
- Manufacturer: Shenyang Sunshine Pharmaceutical Co., LTD. — full pipeline
- Also known as: SSS11